Intelligent Bio Solutions (INBS) EBT Margin (2020 - 2024)
Historic EBT Margin for Intelligent Bio Solutions (INBS) over the last 5 years, with Q1 2024 value amounting to 362.44%.
- Intelligent Bio Solutions' EBT Margin rose 10273200.0% to 362.44% in Q1 2024 from the same period last year, while for Mar 2024 it was 363.35%, marking a year-over-year increase of 1423600.0%. This contributed to the annual value of 1001.34% for FY2023, which is 4692900.0% down from last year.
- Per Intelligent Bio Solutions' latest filing, its EBT Margin stood at 362.44% for Q1 2024, which was up 10273200.0% from 264.42% recorded in Q4 2023.
- Intelligent Bio Solutions' 5-year EBT Margin high stood at 174.6% for Q2 2022, and its period low was 9164.97% during Q1 2021.
- In the last 5 years, Intelligent Bio Solutions' EBT Margin had a median value of 597.03% in 2022 and averaged 1429.69%.
- As far as peak fluctuations go, Intelligent Bio Solutions' EBT Margin skyrocketed by 84667200bps in 2022, and later plummeted by -6915100bps in 2023.
- Over the past 5 years, Intelligent Bio Solutions' EBT Margin (Quarter) stood at 1942.94% in 2020, then soared by 90bps to 200.33% in 2021, then crashed by -198bps to 597.03% in 2022, then soared by 56bps to 264.42% in 2023, then crashed by -37bps to 362.44% in 2024.
- Its EBT Margin stands at 362.44% for Q1 2024, versus 264.42% for Q4 2023 and 322.03% for Q3 2023.